- Home
- INVA vs EVH Comparison
INVA vs EVH Comparison
Compare INVA & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- EVH
- Stock Information
- Founded
- INVA 1996
- EVH 2011
- Country
- INVA United States
- EVH United States
- Employees
- INVA N/A
- EVH N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- EVH Other Consumer Services
- Sector
- INVA Health Care
- EVH Consumer Discretionary
- Exchange
- INVA Nasdaq
- EVH Nasdaq
- Market Cap
- INVA 1.3B
- EVH 1.1B
- IPO Year
- INVA 2004
- EVH 2015
- Fundamental
- Price
- INVA $20.48
- EVH $9.62
- Analyst Decision
- INVA Strong Buy
- EVH Strong Buy
- Analyst Count
- INVA 4
- EVH 14
- Target Price
- INVA $40.25
- EVH $17.07
- AVG Volume (30 Days)
- INVA 790.8K
- EVH 3.8M
- Earning Date
- INVA 11-05-2025
- EVH 11-06-2025
- Dividend Yield
- INVA N/A
- EVH N/A
- EPS Growth
- INVA N/A
- EVH N/A
- EPS
- INVA 0.53
- EVH N/A
- Revenue
- INVA $370,229,000.00
- EVH $2,195,920,000.00
- Revenue This Year
- INVA $8.17
- EVH N/A
- Revenue Next Year
- INVA $12.06
- EVH $25.04
- P/E Ratio
- INVA $38.42
- EVH N/A
- Revenue Growth
- INVA 12.02
- EVH N/A
- 52 Week Low
- INVA $16.67
- EVH $7.06
- 52 Week High
- INVA $22.00
- EVH $31.80
- Technical
- Relative Strength Index (RSI)
- INVA 56.42
- EVH 51.68
- Support Level
- INVA $19.60
- EVH $9.28
- Resistance Level
- INVA $21.11
- EVH $9.80
- Average True Range (ATR)
- INVA 0.51
- EVH 0.51
- MACD
- INVA 0.05
- EVH 0.07
- Stochastic Oscillator
- INVA 57.89
- EVH 70.00
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.